Researchers discovered lolamicin, a selective Gram-negative antibiotic, effective against multidrug-resistant pathogens while sparing the gut microbiome.
Researchers discovered lolamicin, a selective Gram-negative antibiotic, effective against multidrug-resistant pathogens while sparing the gut microbiome.